VINCERX PHARMA INC's ticker is VINC and the CUSIP is 92731L106. A total of 56 filers reported holding VINCERX PHARMA INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,166 | -50.3% | 37,054 | -37.2% | 0.00% | – |
| Q2 2023 | $76,747 | +86132.6% | 59,036 | -30.7% | 0.00% | – |
| Q1 2023 | $89 | +25.4% | 85,175 | +21.5% | 0.00% | – |
| Q4 2022 | $71 | -100.0% | 70,076 | -66.2% | 0.00% | – |
| Q3 2022 | $287,000 | -29.1% | 207,612 | -32.3% | 0.00% | – |
| Q2 2022 | $405,000 | +118.9% | 306,598 | +562.4% | 0.00% | – |
| Q1 2022 | $185,000 | -66.1% | 46,288 | -13.4% | 0.00% | – |
| Q4 2021 | $545,000 | -17.8% | 53,437 | +4.7% | 0.00% | – |
| Q2 2021 | $663,000 | -56.0% | 51,043 | -34.7% | 0.00% | -100.0% |
| Q1 2021 | $1,508,000 | – | 78,139 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAGE RHINO CAPITAL LLC | 1,658,199 | $2,189,000 | 0.84% |
| Affinity Asset Advisors, LLC | 1,374,098 | $1,814,000 | 0.76% |
| SABBY MANAGEMENT, LLC | 500,559 | $661,000 | 0.45% |
| TANG CAPITAL MANAGEMENT LLC | 1,030,634 | $1,360,000 | 0.21% |
| Rubric Capital Management LP | 2,107,000 | $2,781,000 | 0.15% |
| Long Focus Capital Management, LLC | 980,000 | $1,294,000 | 0.14% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 385,000 | $508,000 | 0.09% |
| Clearline Capital LP | 452,184 | $597,000 | 0.08% |
| Sio Capital Management, LLC | 102,049 | $135,000 | 0.05% |
| Rock Springs Capital Management LP | 814,194 | $1,075,000 | 0.03% |